Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretionopathy induced by macrophages

@article{Hui1993CorticosteroidsAD,
  title={Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretionopathy induced by macrophages},
  author={Yan-nian Hui and H Z Liang and Y. S. Cai and Bernd Kirchhof and Klaus Heimann},
  journal={Graefe's Archive for Clinical and Experimental Ophthalmology},
  year={1993},
  volume={231},
  pages={109-114}
}
An experimental model of proliferative vitreoretionpathy (PVR) induced by macrophages simulates a special form of wound healing process in the eye and mimics the development of PVR from its initial stage. We used this model for the evaluation of drug efficacy in the prevention of PVR. One mg triamcinolone acetonide (TA), 10 μg daunomycin-liposome (DL), 5 μg free daunomycin (FD) and 0.1 ml saline or empty liposomes (as controls) were injected into the vitreous in four groups of animals (30 or 40… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 36 references

The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy

  • DB Chandler, G Rozakis, E de Juan, R Machemer
  • Am J Ophthalmol
  • 1985
Highly Influential
4 Excerpts

Drug delivery systems for treatment of proliferative vitreoretinopathy

  • WH Stern, TD Heath
  • In: Ryan SJ (ed) Retina, CV Mosby, St Louis,
  • 1989

Similar Papers

Loading similar papers…